The protein "T cell receptor alpha variable 12D-1," abbreviated as TRAV12D-1, is a component of the T cell receptor (TCR) complex, which plays a pivotal role in the adaptive immune system. TCRs are heterodimeric proteins typically comprising an alpha (α) and a beta (β) chain, although in some T cells, known as gamma delta (γδ) T cells, the receptor is made up of gamma (γ) and delta (δ) chains.TRAV12D-1 specifically refers to one of the variable (V) domains of the alpha chain of the TCR. These variable domains are crucial for antigen recognition, as they directly interact with peptide antigens presented by Major Histocompatibility Complex (MHC) molecules on antigen-presenting cells. The "12D-1" designation indicates a particular variable segment within the vast repertoire of TCR alpha chains, each of which can contribute to the immense diversity of the TCRs generated by the immune system through a process called V(D)J recombination.
The V(D)J recombination process randomly combines variable (V), diversity (D), and joining (J) gene segments, along with random insertions and deletions at the junctions, to generate a unique antigen-binding site for each TCR. This diversity enables the immune system to recognize a vast array of antigens. The TRAV12D-1 segment specifically contributes to this diversity by providing one of the many variable domains that can be used in the generation of TCR alpha chains.The specificity and sensitivity of TCRs bearing the TRAV12D-1 segment depend on the particular combination of V, D, and J segments, as well as the pairing with a TCR beta chain. These receptors are tested during T cell development for their ability to recognize antigens while avoiding autoimmunity. T cells that successfully pass this selection process exit the thymus and circulate in the body, ready to respond to pathogens or diseased cells. The TRAV12D-1-containing TCRs, therefore, are integral to the targeted immune response, capable of distinguishing between self and non-self, and initiating an immune response when they encounter their specific antigen.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib could potentially inhibit T cell receptor alpha variable 12D-1 expression by modulating the activity of kinases involved in its gene regulation, thus reducing its synthesis. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin might inhibit T cell receptor alpha variable 12D-1 expression by modulating histone acetylation patterns, affecting accessibility of its gene for transcription. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib may inhibit T cell receptor alpha variable 12D-1 expression by interfering with cell cycle progression, thus reducing the proliferation of T cells expressing this receptor. | ||||||
AZD2014 | 1009298-59-2 | sc-364420 | 5 mg | $303.00 | 2 | |
AZD-8055 could potentially inhibit T cell receptor alpha variable 12D-1 expression by interfering with mTOR signaling pathways crucial for its transcriptional regulation, downregulating its synthesis. | ||||||
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $184.00 $321.00 | 2 | |
Nintedanib might inhibit T cell receptor alpha variable 12D-1 expression by modulating the activity of transcription factors crucial for its gene regulation and subsequent protein synthesis. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib may inhibit T cell receptor alpha variable 12D-1 expression by interfering with BTK signaling pathways crucial for its transcriptional regulation, thus downregulating its synthesis. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib could potentially inhibit T cell receptor alpha variable 12D-1 expression by modulating the activity of signaling pathways crucial for its transcriptional regulation, downregulating its synthesis. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
Everolimus may inhibit T cell receptor alpha variable 12D-1 expression by interfering with mTORC1 signaling pathways crucial for its transcriptional regulation, downregulating its synthesis. | ||||||
Vemurafenib | 918504-65-1 | sc-364643 sc-364643A | 10 mg 50 mg | $117.00 $423.00 | 11 | |
Vemurafenib could potentially inhibit T cell receptor alpha variable 12D-1 expression by interfering with RAF/MEK/ERK signaling pathways crucial for its transcriptional regulation, downregulating its synthesis. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
Venetoclax might inhibit T cell receptor alpha variable 12D-1 expression by modulating the activity of transcription factors crucial for its gene regulation and subsequent protein synthesis. | ||||||